CBX-250 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

Crossbow Therapeutics, Inc.1

Indications

Chronic Myelomonocytic Leukemia (CMML)1
Chronic Myeloid Leukemia1
AML - Acute Myeloid Leukemia1
High-risk Myelodysplastic Syndrome1
Cancer1

Duarte, California1 trial

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

City of Hope

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.